SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 23, 2001
BIOTRANSPLANT INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware 000-28324 04-3119555
------------------------------- ------------------------ -------------------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
Building 75, Third Avenue
Charlestown Navy Yard
Charlestown, MA 02129
------------------------------------- ------------------------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code: (617) 241-5200
N/A
---------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On December 11, 2000, BioTransplant Incorporated ("BioTransplant")
announced its plans to acquire Eligix, Inc. ("Eligix") pursuant to an Agreement
and Plan of Merger entered into on December 8, 2000. Prior to the closing of the
merger, Eligix will borrow up to $2.0 million from BioTransplant to fund
operations. The loan is evidenced by a promissory note, which was entered into
on January 23, 2001 and bears interest at the prime rate. The loan will be
forgiven concurrently with the closing of the merger, provided that if the
merger does not close on or before June 31, 2001, then the note will become
immediately due and payable.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits.
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: March 9, 2001 BIOTRANSPLANT INCORPORATED
By: /s/ Richard V. Capasso
--------------------------------
Richard V. Capasso
Vice President, Finance and Treasurer
EXHIBIT INDEX
Exhibit No. Exhibit
----------- -------
Exhibit 10.1 Promissory Note made on January 23, 2001 by
Eligix, Inc. in favor of BioTransplant Incorporated